Advertisement
Advertisement
GLSI
Greenwich LifeSciences, Inc.
25.30
USDSponsored
+0.59
+2.39%
May 13, 16:00 UTC -4
Closed
Pre-Market
25.40
+0.10
+0.40%
GLSI Earnings Reports
Positive Surprise Ratio
GLSI beat 11 of 18 last estimates.
61%
Next Report
Next Week
Date of Next Report
May 18, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.33
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q1 25 (Revenue/ EPS)
--
/+32.00%
Greenwich LifeSciences, Inc. earnings per share and revenue
On May 13, 2026, GLSI reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.32 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q1 26, 3 analysts forecast an EPS of -0.33 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Longeveron Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-12.89%
Bionano Genomics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.96
Actual
-$0.76
Surprise
+21.57%
FAQ
What were Greenwich LifeSciences, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Greenwich LifeSciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Greenwich LifeSciences, Inc.'s Q4 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Greenwich LifeSciences, Inc. expected to report next?
The next earning report is scheduled for May 18, 2026.
What are the forecasts for Greenwich LifeSciences, Inc.'s next earnings report?
Based on 3
analysts, Greenwich LifeSciences, Inc. is expected to report EPS of -$0.33 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement